AMT Medical

AMT Medical is a private, pre-revenue medical device innovator focused on transforming coronary bypass surgery. Its core technology, the Elana® Anastomotic System, adapts a laser-based anastomosis platform from neurosurgery to create a standardized connection between a graft and a coronary artery on a beating heart. The company's mission is to drive the adoption of less invasive CABG techniques (like MIDCAB and TECAB) by reducing procedural complexity and dependence on high surgical skill. AMT Medical is in the development and regulatory phase, collaborating with leading European cardiac centers to advance its system toward clinical use.

The Elana® (Excimer Laser Assisted Non-occlusive Anastomosis) platform, originally from neurosurgery, uses a clip and laser catheter to create a standardized, sutureless anastomosis on a beating heart without occluding the target vessel.

Competition includes large medtech companies with dominant positions in cardiac surgery tools and suture technologies, as well as companies developing robotic surgical systems. AMT's specific laser-based, non-occlusive anastomosis approach appears to be a differentiated niche solution.